2020 annual financial data

China SXT Pharmaceuticals 2020 Financial results

Direct answer

Revenue was 5,162,268 USD.

Operating income was -1,341,117 USD and net income was -10,287,872 USD.
Operating cash flow was 934,247 USD.

Get free China SXT Pharmaceuticals email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
5,162,268 USD
Operating income
-1,341,117 USD
Net income
-10,287,872 USD
Operating cash flow
934,247 USD